文献速递儿童青少年精神

ADHD患者hiPSC来源皮层神经元显示谷氨酸能发育失调

hiPSC-derived cortical neurons from ADHD individuals reveal dysregulated glutamatergic development.
PubMed 文献 · Mol Psychiatry · 2025-09-19

研究利用健康对照与成人ADHD患者的hiPSC建立功能性皮层神经元模型,发现ADHD来源神经元虽能形成皮层神经元,但呈现谷氨酸释放改变、NEUN/PSD95/EEAT2转录下降及vGLUT2转录约50%降低,钙成像显示突触信号强度和频率下降,提示谷氨酸能发育受损。

要点

  • ADHD患者hiPSC来源皮层神经元存在谷氨酸能发育异常。
  • vGLUT2转录在多个时间点约降低50%,或为稳健细胞内表型。
  • 钙成像显示突触信号强度与频率下降,呈低活跃表型。

核心结论

  • ADHD个体hiPSC来源皮层神经元显示谷氨酸能发育受损,谷氨酸系统应成为未来药物开发靶点。

研究设计与样本

  • 研究建立并表征健康对照与成人ADHD患者hiPSC来源的功能性皮层神经元模型。

主要发现

  • 健康对照与ADHD来源hiPSC形成皮层神经元的能力无差异。
  • ADHD来源皮层神经元呈改变的发展模式,包括细胞外谷氨酸变化及NEUN、PSD95和EEAT2转录下降。
  • 多个时间点观察到vGLUT2转录显著降低约50%。
  • 钙成像分析显示突触信号强度和频率下降,提示低活跃表型。

临床怎么用

  • 该hiPSC来源皮层神经元模型或适用于未来药物筛选。
  • ADHD未来药物开发可考虑以谷氨酸系统为靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Attention-deficit/hyperactivity disorder (ADHD) is a chronic neurodevelopmental disorder characterised by inattention, hyperactivity, and impulsivity, significantly impacting life quality and mortality. It is among the most heritable neuropsychiatric disorders, yet its aetiology remains unclear, hindering the development of novel medications. Previously, research has primarily focused on the dopaminergic and noradrenergic systems using animal models. However, there is growing evidence for a role of the glutamatergic system in ADHD pathomechanisms, and a translational failure between pre-clinical animal models and human clinical trials. We therefore established and characterised a functional cortical neuronal model using human induced pluripotent stem cells (hiPSCs) to investigate glutamatergic development in healthy controls and adult ADHD patients. hiPSCs from healthy controls and ADHD patients showed no difference in their capacity to form cortical neurons (CNs). However, CNs from ADHD patients showed an altered developmental pattern, characterised by changes in extracellular glutamate and decreased transcription of NEUN, PSD95 and EEAT2. Moreover, a significant ~50% reduction in vGLUT2 transcription was observed at multiple time points, suggesting a robust cellular disease endophenotype which might be suitable for future drug screening. Lastly, calcium imaging analysis revealed decreased synaptic signalling strength and frequency, indicating a hypoactive phenotype. In summary, we were able to establish a functional hiPSC-derived cortical neuronal model to investigate ADHD pathomechanisms, which revealed impaired glutamatergic development in ADHD individuals. Our results suggest that the glutamatergic system should also be a target for future drug development.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. McNeill RV, Schickardt Z, Radtke F, et al. hiPSC-derived cortical neurons from ADHD individuals reveal dysregulated glutamatergic development. Mol Psychiatry. 2025. PMID: 40973785. doi:10.1038/s41380-025-03213-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。